Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-18T09:29:29.043Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost-effectiveness evaluation of compliance therapy for people with psychosis

Published online by Cambridge University Press:  03 January 2018

Andrew Healey ,
Martin Knapp ,
Jack Astin ,
Jennifer Beecham ,
Roisin Kemp ,
Anthony David  and
George Kirov
Andrew Healey*
Affiliation:
Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London SE5 8AZ
Martin Knapp
Affiliation:
Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London SE5 8AZ
Jack Astin
Affiliation:
Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London SE5 8AZ
Jennifer Beecham
Affiliation:
Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London SE5 8AZ
Roisin Kemp
Affiliation:
University Department of Psychiatry, Royal Free Hospital, Pond Street, London NW3 2QG
Anthony David
Affiliation:
Department of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AZ
George Kirov
Affiliation:
Department of Psychological Medicine, University of Wales, College of Medicine, Heath Park, Cardiff CS4 4XN
*
Mr Andrew Healey, Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London NW3 2QG
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Non-compliance rates with antipsychotic medication can be high, and the personal and societal costs are considerable. A new psychological intervention, compliance therapy seeks to improve compliance and patient outcomes and reduce treatment costs.

Method

A randomised controlled study examined the cost-effectiveness of compliance therapy compared to nonspecific counselling over 18 months for 74 people with psychosis admitted as inpatients at the Maudsley Hospital. Bivariate and multivariate analyses were conducted to test for differences and to explore inter-patient cost variations.

Results

Compliance therapy is more effective and is no more expensive. Consequently, compliance therapy is more cost-effective than non-specific counselling at six, 12 and 18 months.

Conclusions

There are compliance, outcome and cost-effectiveness arguments in favour of compliance therapy in preference to non-specific counselling.

Type
Papers
Information
The British Journal of Psychiatry , Volume 172 , Issue 5 , May 1998 , pp. 420 - 424
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

†

Related paper pp. 413–419, this issue.

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Barnes, T. R. E. (1989) A rating scale for drug induced akathisia. British Journal of Psychiatry, 54, 672–676.CrossRefGoogle Scholar
Beecham, J. K. & Knapp, M. R. J. (1991) Costing psychiatric interventions. In Measuring Mental Health Needs (eds G. Thornicroft, C. Brewin & J. K. Wing), pp. 163–183. London: Gaskell.Google Scholar
Corrigan, P. W., Liberman, R. P. & Engel, J. D. (1990) From non-compliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry, 41, 1203–1211.Google Scholar
David, A. S. (1990) Insight and psychosis. British Journal of Psychiatry. 156, 798–808.CrossRefGoogle ScholarPubMed
Hale, T. (1993) Will the new antipsychotics improve the treatment of schizophrenia. British Medical Journal, 307, 749–750.CrossRefGoogle ScholarPubMed
Hayward, P., Chan, N., Kemp, R., et al (1995) Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health, 4, 511–517.CrossRefGoogle Scholar
Hogan, T. P., Awad, A. G. & Eastwood, R. (1983) A self report scale predictive of drug compliance in schizophrenia: reliability and discriminative validity. Psychological Medicine, 13, 177–183.CrossRefGoogle ScholarPubMed
Lukoff, D., Nuechterlein, K. H. & Ventura, J. (1996) Manual for the expanded BPRS. Schizophrenia Bulletin, 12, 594–602.Google Scholar
Kemp, R., David, A. & Hayward, P. (1996a) Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy, 24, 331–350.CrossRefGoogle Scholar
Kemp, R., Hayward, P., Applethwaite, G., et al (1996b) Compliance therapy in psychotic patients: a randomised controlled trial. British Medical Journal, 312, 345–349.CrossRefGoogle ScholarPubMed
Kemp, R., & Hayward, P., (1997) Insight and compliance. In Compliance and the Treatment Alliance in Serious Mental Illness. Newark: B. Blackwell, Gordon and Breach Publishing Group.Google Scholar
Kemp, R., Kirov, G., Everitt, B., et al (1998) A randomised controlled trial of compliance therapy: 18 month follow-up. British Journal of Psychiatry, 172, 413–419.CrossRefGoogle ScholarPubMed
MacPhillips, M. & Sensky, T. (1998) Coercion, adherence or collaboration? Influences on compliance with medication. In Innovation in the Psychological Treatment of Schizophrenia (ed. Wykes, T.). Chichester: John Wiley, in press.Google Scholar
Nelson, H. E. (1982) National Adult Reading Test (NART): Test Manual. Windsor: NFER.Google Scholar
Netten, A. & Dennett, J. (1996) Unit Costs of Health and Social Care 1996. Personal Social Services Research Unit, University of Kent at Canterbury.Google Scholar
Simpson, G. M. & Angus, J. W. S. (1970) Drug-induced extrapyramidal disorders. Acta Psychiotrica Scandinavica, 45 (suppl. 212): 11–19.CrossRefGoogle Scholar
Weiden, P. J. & Olfson, M. (1995) Costs of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419–429.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.